Answers are grounded in this paper and cite their sources.
This study assessed the in vivo distribution of ¹¹C-nicotine and the absorbed radiation dose from whole-body ¹¹C-nicotine PET imaging of 11 healthy (5 male and 6 female) subjects. Methods: After an initial CT attenuation scan, ¹¹C-nicotine was administered via intravenous injection. A dynamic PET scan was acquired for 90 s with the brain in the field of view, followed by a series of 13 whole-body PET scans acquired over a 90-min period. Regions of interest were drawn over organs visible in the reconstructed PET images. Time–activity curves were generated, and the residence times were calculated. The absorbed radiation dose for the whole body was calculated by entering the residence time in OLINDA/EXM 1.0 software to model the equivalent organ dose and the effective dose for a 70-kg man. Results: The mean residence times for ¹¹C-nicotine in the liver, red marrow, brain, and lungs were 0.048 ± 0.010, 0.031 ± 0.005, 0.021 ± 0.004, and 0.020 ± 0.005 h, respectively. The mean effective dose for ¹¹C-nicotine was 5.44 ± 0.67 μSv/MBq. The organs receiving the highest absorbed dose from the ¹¹C-nicotine injection were the urinary bladder wall (14.68 ± 8.70 μSv/MBq), kidneys (9.56 ± 2.46 μSv/MBq), liver (8.94 ± 1.67 μSv/MBq), and spleen (9.49 ± 3.89 μSv/MBq). The renal and hepatobiliary systems were the major clearance and excretion routes for radioactivity. Conclusion: The estimated radiation dose from ¹¹C-nicotine administration is relatively modest and would allow for multiple PET examinations on the same subject.
No takes yet. Share an insight, caveat, or question.
Garg et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: